Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

PET scanning for patients with small-cell lung cancer

Posted by on Mar 19, 2019 in Lung cancer | 0 comments

In a nutshell This study determined whether PET scanning helps improve overall survival for patients with small-cell lung cancer (SCLC). This study found that overall survival was significantly longer in patients with SCLC who had PET scanning. Some background Determining the disease stage for patients with SCLC is a key part of determining the...

Read More

Safety of nivolumab and radiation therapy in patients with NSCLC that has spread

Posted by on Mar 19, 2019 in Lung cancer | 0 comments

In a nutshell This study evaluated the safety of nivolumab (Opdivo) combined with radiation therapy for patients with advanced non-small cell lung cancer (NSCLC) that has spread. This study found that radiation therapy before or after treatment with nivolumab was not associated with an increased risk of severe side effects. Some background...

Read More

SBRT vs. radiotherapy in patients with inoperable non-small cell lung cancer

Posted by on Mar 5, 2019 in Lung cancer | 0 comments

In a nutshell This study determined whether stereotactic body radiation therapy (SBRT) was more effective than standard radiotherapy in patients with inoperable non-small cell lung cancer. The study found that SBRT led to better survival outcomes for these patients, with minimal side effects. Some background Tumor removal by surgery is the standard of...

Read More

SBRT vs. radiotherapy in patients with inoperable non-small cell lung cancer

Posted by on Mar 5, 2019 in Lung cancer | 0 comments

In a nutshell This study determined whether stereotactic body radiation therapy (SBRT) was more effective than standard radiotherapy in patients with inoperable non-small cell lung cancer. The study found that SBRT led to better survival outcomes for these patients, with minimal side effects. Some background Tumor removal by surgery is the standard of...

Read More

Oncolytic Virus Treatments

Oncolytic Virus Treatments

Posted by on Feb 10, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Prostate cancer | 0 comments

In 1904, a physician wrote about a patient with leukemia who went into remission when he got the flu. Though the patient was not cured, it was a ray of hope at a time when there were no treatments for leukemia. Other cases were reported throughout the years of people with Burkitt’s Lymphoma and Hodgkin’s Lymphoma going into remission when they...

Read More

Precautionary radiation therapy on the brain for patients with small cell lung cancer

Posted by on Feb 5, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out how effective it is to perform radiation therapy on the brain to prevent lung cancer spreading to the brain. The study found that by performing radiation therapy on the brain, there was a lower chance of the cancer spreading to the brain, but it was not clear if it improved overall survival. Some background...

Read More

ASCO’s National Cancer Opinion Survey Results

ASCO’s National Cancer Opinion Survey Results

Posted by on Jan 24, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 0 comments

During July and early August of  2018, the Harris Poll in association with the American Society of Clinical Oncologists (ASCO’s) conducted a poll of 4,887 U.S. adults, 1001 of these have or had cancer. This second annual National Cancer Opinion Survey explored a wide range of topics. The findings clearly describe disparities in the care patients with...

Read More

Effects on survival: thermal ablation vs stereotactic radiation therapy for non-small cell lung cancer

Posted by on Jan 20, 2019 in Lung cancer | 0 comments

In a nutshell This article investigated the safety and effectiveness of thermal ablation (TA) compared to stereotactic radiation therapy (SRT) for the treatment of non-small-cell lung cancer (NSCLC). The authors concluded that both thermal ablation and stereotactic radiation are safe and can improve survival of these patients. Some...

Read More

Is the biosimilar drug ABP 125 as effective as bevacizumab in patients with lung cancer?

Posted by on Jan 17, 2019 in Lung cancer | 0 comments

In a nutshell This study examined how safe and effective is biosimilar ABP 215 in non-small cell lung cancer (NSCLC), compared to bevacizumab (Avastin). This study concluded that this drug is as safe and effective as bevacizumab in these patients. Some background Non-small cell lung cancer (NSCLC) is the most common type of lung...

Read More